daunorubicin has been researched along with menogaril in 44 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 38 (86.36) | 18.7374 |
1990's | 6 (13.64) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Satoh, H; Taguchi, H; Yahagi, S | 1 |
Matsuo, K; Sugimoto, Y; Takeda, S; Tsukagoshi, S; Yamada, Y | 1 |
Earhart, RH; Maroun, JA; Robillard, L; Stewart, DJ; Verma, S | 1 |
Ahmann, FR; Chapman, R; Crawford, ED; Goodman, P; Lowe, BA; Natale, RB; Spicer, CF; Stephens, RL | 1 |
Matsuo, K; Sugimoto, Y; Takeda, S; Toko, T; Tsukagoshi, S; Wierzba, K; Yamada, Y | 1 |
Atwell, J; Politi, PM; Sinha, BK | 1 |
Cole, SP; Gerlach, JH; Mirski, SE | 1 |
Bungo, M; Fujiwara, Y; Fukuda, M; Horichi, N; Minato, K; Nakagawa, K; Niimi, S; Ohe, Y; Saijo, N; Sasaki, Y | 1 |
Cavalli, F; Kaye, SB; Renard, J; Sessa, C; ten Bokkel Huinink, W | 1 |
Buckner, JC; Edmonson, JH; Ingle, JN; Schaid, DJ | 1 |
Adams, WJ; Brewer, JE; Dalm, EA; Hosley, JD; McGovren, JP | 1 |
Earhart, RH; Maroun, JA; Perrault, D; Stewart, DJ; Verma, S | 1 |
Dombernowsky, P; Hansen, M; Joss, RA; Monfardini, S; Pinedo, HM; Renard, J | 1 |
Cheng, E; Chuang, YJ; Niedzwiecki, D; Sordillo, PP; Sternberg, CN | 1 |
Ganapathi, R; Grabowski, D; Israel, M; Schmidt, H; Seshadri, R | 1 |
Bachur, NR; Dodion, P; Egorin, MJ; Engisch, KL | 1 |
Adams, EG; Bhuyan, BK; Crampton, SL; Johnson, M | 1 |
Aisner, J; Egorin, MJ; Engisch, KL; Forrest, A; Sigman, LM; Van Echo, DA; Whitacre, MY | 1 |
Raymond, V; Young, CW | 1 |
Dorr, FA; Kisner, DL; Kuhn, JG; Schwartz, R; Von Hoff, DD | 1 |
Dodion, P; Kenis, Y; Kitt, MM; Klastersky, J; Rombaut, W; Rozencweig, M; Sanders, C | 1 |
Ratain, MJ; Schilsky, RL | 1 |
Aisner, J; Egorin, MJ; Sigman, LM; Van Echo, DA; Whitacre, MY | 1 |
Adams, EG; Bhuyan, BK | 1 |
Capizzi, RL; Chandrasekaran, B; Dimling, J | 1 |
Clagett-Carr, K; Leyland-Jones, B; Russo, M; Sarosy, G; Weiss, RB | 1 |
Brown, TD; Donehower, RC; Ettinger, DS; Grochow, LB; Rice, AP | 1 |
Long, HJ; Moertel, CG; Powis, G; Schutt, AJ | 1 |
Barrett, J; Benson, AB; Blough, R; Chernicoff, D; Hoeltgen, T; Johnson, C; Kilton, L; Knop, RH; Locker, GY | 1 |
D'Incalci, M; Figoli, F; Monfardini, S; Sorio, R; Tirelli, U; Zadro, D; Zanette, ML | 1 |
Conley, BA; Egorin, MJ; Forrest, A; Sinibaldi, V; Van Echo, DA; Zuhowski, EG | 1 |
Gundersen, S; Monfardini, S; Pinedo, H; Renard, G; Van Glabbeke, M | 1 |
Cheng, EW; Hollander, P; Magill, GB; Sternberg, CN | 1 |
Crespeigne, N; de Valeriola, D; Dodion, P; Joggi, J; Kenis, Y; Peeters, B; Piccart, M; Tueni, E; van Berchem, C; Wery, F | 1 |
Cavalli, F; Gundersen, S; Renard, J; Sessa, C; ten Bokkel Huinink, W | 1 |
Edmonson, JH; Ingle, JN; Long, HJ; Loprinzi, CL; Schaid, DJ; Schutt, AJ | 1 |
Decoster, G; Holdener, EE; Ludwig, C; Pinedo, HM; Renard, G; ten Bokkel Huinink, WW | 1 |
Crespeigne, N; de Valeriola, D; Dodion, P; Joggi, J; Kenis, Y; Peeters, B; van Berchem, C; Wery, F | 1 |
Bhuyan, BK; Harbach, PR; Johnson, MA; Mazurek, JH; Shu, VS; Trzos, RJ; Zimmer, DM | 1 |
Adams, WJ; Hamilton, RD; McGovren, JP; Pratt, EA | 1 |
Christopher, JP; Cradock, JC; Lassus, M; McGovren, JP; Nelson, KG; Plowman, J | 1 |
Bhuyan, BK; Crampton, SL; McGovren, JP | 1 |
Adams, EG; Bhuyan, BK; Crampton, SL | 1 |
Brown, JE; Brown, JR; Wilkinson, PA | 1 |
2 review(s) available for daunorubicin and menogaril
Article | Year |
---|---|
Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
Topics: Aclarubicin; Anthraquinones; Antibiotics, Antineoplastic; Breast Neoplasms; Carubicin; Cell Survival; Daunorubicin; Doxorubicin; Drug Evaluation; Epirubicin; Heart; Humans; Idarubicin; Leukemia; Menogaril; Mitoxantrone; Naphthacenes; Nogalamycin; Sarcoma; Structure-Activity Relationship | 1986 |
Anthracycline analogs: the past, present, and future.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Epirubicin; Female; Guinea Pigs; Heart; Humans; Idarubicin; Male; Menogaril; Mice; Nogalamycin; Rabbits; Rats | 1986 |
3 trial(s) available for daunorubicin and menogaril
Article | Year |
---|---|
Anthracycline analogs: the past, present, and future.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Epirubicin; Female; Guinea Pigs; Heart; Humans; Idarubicin; Male; Menogaril; Mice; Nogalamycin; Rabbits; Rats | 1986 |
Phase II trial of menogaril in advanced colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Colorectal Neoplasms; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Female; Hematologic Tests; Humans; Male; Menogaril; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Nogalamycin | 1988 |
Menogaril: a new anthracycline agent entering clinical trials.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Clinical Trials as Topic; Cricetinae; Cricetulus; Daunorubicin; Dogs; Humans; Injections, Intravenous; Macaca mulatta; Menogaril; Mutagens; Neoplasms, Experimental; Nogalamycin; Rabbits; Rats; Rats, Inbred Strains | 1984 |
40 other study(ies) available for daunorubicin and menogaril
Article | Year |
---|---|
[Antitumor spectrum of TUT-7 on rat ascitic hepatoma].
Topics: Animals; Antineoplastic Agents; Daunorubicin; Drug Evaluation, Preclinical; Female; Liver Neoplasms, Experimental; Menogaril; Nogalamycin; Rats; Rats, Inbred Strains | 1990 |
[Antitumor activities of orally administered 7-con-0-methylnogarol (TUT-7)].
Topics: Administration, Oral; Animals; Antineoplastic Agents; Colonic Neoplasms; Daunorubicin; Doxorubicin; Humans; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Lung Neoplasms; Menogaril; Mice; Nogalamycin; Rats; Sarcoma, Yoshida | 1990 |
Phase I study of oral menogaril administered on a once weekly schedule.
Topics: Administration, Oral; Adult; Antineoplastic Agents; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Female; Hematologic Diseases; Humans; Male; Menogaril; Nogalamycin | 1990 |
Evaluation of menogaril in renal cell carcinoma. A Southwest Oncology Group phase II study (8504).
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Daunorubicin; Drug Evaluation; Humans; Kidney Neoplasms; Menogaril; Nogalamycin | 1990 |
Menogaril, an anthracycline compound with a novel mechanism of action: cellular pharmacology.
Topics: Animals; Antineoplastic Agents; Daunorubicin; DNA Damage; DNA, Neoplasm; Doxorubicin; Leukemia L1210; Menogaril; Microtubule Proteins; Neoplasm Proteins; Nogalamycin; Polyphosphates; RNA, Neoplasm; Tubulin | 1990 |
Role of oxygen free radical formation in the mechanism of menogaril resistance in multidrug resistant tumor cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Survival; Chemical Phenomena; Chemistry; Daunorubicin; DNA; Doxorubicin; Drug Resistance; Electron Spin Resonance Spectroscopy; Free Radicals; Humans; Menogaril; Nogalamycin; Oxygen; Tumor Cells, Cultured | 1990 |
Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin.
Topics: Animals; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cell Line; Colchicine; Daunorubicin; Doxorubicin; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Epirubicin; Etoposide; Glycoproteins; Gramicidin; Humans; Immunosorbent Techniques; Isoxazoles; Lung Neoplasms; Menogaril; Mice; Mice, Inbred BALB C; Mitoxantrone; Nogalamycin; Phenotype; Vinblastine; Vincristine | 1987 |
In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Bleomycin; Carubicin; Cisplatin; Daunorubicin; Doxorubicin; Drug Resistance; Humans; Menogaril; Mitomycins; Nogalamycin; Tumor Cells, Cultured | 1989 |
Phase II study of intravenous menogaril in advanced ovarian carcinoma. EORTC Early Clinical Trials Group.
Topics: Adult; Aged; Antineoplastic Agents; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Menogaril; Middle Aged; Nogalamycin; Ovarian Neoplasms | 1989 |
Evaluation of menogaril in patients with metastatic sarcomas and no prior chemotherapy exposure.
Topics: Adult; Aged; Antineoplastic Agents; Daunorubicin; Drug Evaluation; Female; Humans; Leukopenia; Male; Menogaril; Middle Aged; Nogalamycin; Sarcoma | 1989 |
Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Biological Availability; Daunorubicin; Dogs; Female; Injections, Intravenous; Leukemia P388; Macaca mulatta; Menogaril; Mice; Mice, Inbred Strains; Nogalamycin; Species Specificity | 1989 |
Phase I study of weekly intravenous administration of menogaril to adults with solid tumors.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents; Daunorubicin; Dexamethasone; Drug Administration Schedule; Drug Evaluation; Female; Humans; Injections, Intravenous; Male; Menogaril; Middle Aged; Neoplasms; Nogalamycin; Prognosis; Thrombocytopenia | 1989 |
Negative phase II trial of menogaril in advanced squamous, adeno- and large cell carcinoma of the lung.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Daunorubicin; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Menogaril; Middle Aged; Nogalamycin | 1988 |
Evaluation of new anticancer agents against human pancreatic carcinomas in nude mice.
Topics: Adult; Aged; Alkaloids; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Intraductal, Noninfiltrating; Daunorubicin; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Male; Menogaril; Mice; Mice, Nude; Microtubules; Neoplasm Transplantation; Nogalamycin; Paclitaxel; Pancreatic Neoplasms; Random Allocation; Transplantation, Heterologous | 1987 |
Calmodulin inhibitor trifluoperazine selectively enhances cytotoxic effects of strong vs weak DNA binding antitumor drugs in doxorubicin-resistant P388 mouse leukemia cells.
Topics: Aminoacridines; Amsacrine; Animals; Anthraquinones; Antibiotics, Antineoplastic; Antineoplastic Agents; Cell Line; Dactinomycin; Daunorubicin; DNA; Doxorubicin; Drug Interactions; Drug Resistance; Leukemia P388; Leukemia, Experimental; Menogaril; Mice; Mitoxantrone; Naphthacenes; Nogalamycin; Trifluoperazine | 1985 |
Metabolism and disposition of menogaril (NSC 269148) in the rabbit.
Topics: Animals; Antineoplastic Agents; Bile; Daunorubicin; Fluorescence; Male; Menogaril; Metabolic Clearance Rate; Nogalamycin; Rabbits; Tissue Distribution | 1985 |
Synergistic combination of menogarol and melphalan and other two drug combinations.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cell Survival; Cells, Cultured; Daunorubicin; Doxorubicin; Drug Synergism; Melanoma; Melphalan; Menogaril; Mice; Nogalamycin | 1985 |
Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicities.
Topics: Antineoplastic Agents; Bile; Biotransformation; Daunorubicin; Dose-Response Relationship, Drug; Humans; Kinetics; Leukocyte Count; Menogaril; Metabolic Clearance Rate; Neutrophils; Nogalamycin | 1986 |
Phase I clinical investigation of 7-con-O-methylnogaril, a new anthracycline antibiotic.
Topics: Antineoplastic Agents; Daunorubicin; Doxorubicin; Drug Evaluation; Hematopoiesis; Humans; Leukocyte Count; Menogaril; Neutrophils; Nogalamycin | 1986 |
In vitro activity of menogaril and N-demethylmenogaril in a human tumor cloning assay.
Topics: Breast Neoplasms; Cell Survival; Daunorubicin; Dose-Response Relationship, Drug; Female; Humans; Menogaril; Neoplastic Stem Cells; Nogalamycin; Ovarian Neoplasms; Tumor Stem Cell Assay | 1986 |
Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicities.
Topics: Daunorubicin; Humans; Menogaril; Models, Theoretical; Nogalamycin | 1986 |
Phase I trial of menogaril administered as an intermittent daily infusion for 5 days.
Topics: Adult; Aged; Antineoplastic Agents; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Female; Hematologic Diseases; Humans; Infusions, Parenteral; Liver Neoplasms; Male; Menogaril; Middle Aged; Neoplasms; Nogalamycin | 1986 |
Effects of 7-R-O-methylnogarol (menogaril) on L1210 cell progression in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line; Daunorubicin; DNA, Neoplasm; Leukemia L1210; Male; Menogaril; Mice; Mice, Inbred Strains; Nogalamycin | 1986 |
Cross-resistance of menogaril and mitoxantrone in a subline of P388 leukemia resistant to doxorubicin.
Topics: Animals; Antineoplastic Agents; Body Weight; Cell Line; Daunorubicin; Doxorubicin; Drug Resistance; Leukemia P388; Life Expectancy; Menogaril; Mice; Mice, Inbred Strains; Mitoxantrone; Nogalamycin | 1987 |
A phase I study of menogaril in patients with advanced cancer.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Daunorubicin; Doxorubicin; Drug Evaluation; Female; Follow-Up Studies; Hematologic Diseases; Humans; Kinetics; Male; Menogaril; Middle Aged; Nausea; Nogalamycin; Stroke Volume | 1987 |
Phase I and pharmacokinetic study of menogaril administered as a 72-hour continuous i.v. infusion.
Topics: Adult; Aged; Daunorubicin; Drug Evaluation; Female; Half-Life; Humans; Infusions, Intravenous; Kinetics; Male; Menogaril; Middle Aged; Neoplasms; Nogalamycin | 1987 |
Phase II trial of menogaril in patients with advanced colorectal carcinoma: an Illinois Cancer Council trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Colonic Neoplasms; Daunorubicin; Drug Evaluation; Female; Humans; Male; Menogaril; Middle Aged; Nogalamycin; Rectal Neoplasms | 1987 |
Pharmacokinetics of 7-con-O-methylnogarol in patients with solid tumors.
Topics: Aged; Daunorubicin; Female; Half-Life; Humans; Infusions, Intravenous; Kinetics; Male; Menogaril; Middle Aged; Neoplasms; Nogalamycin | 1987 |
Phase I study and pharmacokinetics of menogaril (NSC 269148) in patients with hepatic dysfunction.
Topics: Adult; Aged; Antineoplastic Agents; Daunorubicin; Drug Evaluation; Female; Humans; Liver; Liver Function Tests; Male; Menogaril; Middle Aged; Neoplasms; Nogalamycin | 1987 |
Phase II trial of menogaril in advanced malignant melanoma. An EORTC trial.
Topics: Adult; Aged; Antineoplastic Agents; Daunorubicin; Drug Evaluation; Female; Humans; Infusions, Intravenous; Male; Melanoma; Menogaril; Middle Aged; Nogalamycin; Skin Neoplasms | 1987 |
Phase II trial of menogarol in the treatment of advanced adenocarcinoma of the pancreas.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Daunorubicin; Drug Evaluation; Female; Humans; Male; Menogaril; Middle Aged; Nogalamycin; Pancreatic Neoplasms | 1988 |
Phase I clinical and pharmacokinetic trial of oral menogaril administered on three consecutive days.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Biological Availability; Daunorubicin; Drug Evaluation; Female; Half-Life; Humans; Leukopenia; Male; Menogaril; Middle Aged; Neoplasms; Nogalamycin | 1988 |
Phase II study of intravenous menogaril in patients with advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Daunorubicin; Drug Evaluation; Female; Humans; Infusions, Intravenous; Leukopenia; Menogaril; Middle Aged; Nogalamycin; Skin; Thrombocytopenia | 1988 |
Phase II evaluation of menogaril in women with metastatic breast cancer after failure of first-line chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Menogaril; Neoplasm Metastasis; Nogalamycin | 1988 |
Phase I clinical trial of oral menogaril administered on three consecutive days.
Topics: Administration, Oral; Adult; Aged; Blood Cells; Daunorubicin; Drug Evaluation; Female; Heart; Humans; Liver; Male; Menogaril; Middle Aged; Neoplasms; Nogalamycin | 1988 |
Comparative genotoxicity of adriamycin and menogarol, two anthracycline antitumor agents.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Nucleus; Cricetinae; Daunorubicin; Doxorubicin; Lung; Menogaril; Mesocricetus; Microsomes, Liver; Mutagenicity Tests; Mutagens; Mutation; Nogalamycin; Salmonella typhimurium; Structure-Activity Relationship | 1983 |
Quantitation of anthracycline antitumor agent menogarol in plasma using liquid chromatography with fluorescence detection.
Topics: Animals; Antibiotics, Antineoplastic; Chromatography, High Pressure Liquid; Daunorubicin; Dogs; Humans; Menogaril; Mice; Nogalamycin; Spectrometry, Fluorescence | 1984 |
Intracellular uptake of 7-con-o-methylnogarol and adriamycin by cells in culture and its relationship to cell survival.
Topics: Animals; Antibiotics, Antineoplastic; Biological Transport; Cell Cycle; Cell Nucleus; Cell Survival; Cells, Cultured; Cytoplasm; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Guinea Pigs; Menogaril; Mice; Nogalamycin | 1981 |
Effect of 7-con-O-methylnogarol on DNA synthesis, survival, and cell cycle progression of Chinese hamster ovary cells.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Survival; Cells, Cultured; Cricetinae; Cricetulus; Daunorubicin; DNA Replication; Female; Menogaril; Nogalamycin; Ovary; Time Factors | 1981 |
Rapid high-performance liquid chromatographic assay for the anthracyclines daunorubicin and 7-con-O-methylnogarol in plasma.
Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Daunorubicin; Humans; Menogaril; Nogalamycin; Spectrometry, Fluorescence | 1981 |